GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pa Shun International Holdings Ltd (HKSE:00574) » Definitions » YoY EBITDA Growth

Pa Shun International Holdings (HKSE:00574) YoY EBITDA Growth : 120.83% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Pa Shun International Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Pa Shun International Holdings's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 120.83%.

Pa Shun International Holdings's EBITDA per Share for the six months ended in Dec. 2023 was HK$0.01.


Pa Shun International Holdings YoY EBITDA Growth Historical Data

The historical data trend for Pa Shun International Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pa Shun International Holdings YoY EBITDA Growth Chart

Pa Shun International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -388.89 -147.73 22.32 91.34 168.18

Pa Shun International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.12 100.00 90.66 - 120.83

Pa Shun International Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Pa Shun International Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.015--0.022)/ | -0.022 |
=168.18 %

Pa Shun International Holdings's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(0.005--0.024)/ | -0.024 |
=120.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pa Shun International Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Pa Shun International Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Pa Shun International Holdings (HKSE:00574) Business Description

Traded in Other Exchanges
N/A
Address
229 Wufuqiao East Road, No. 608-616, Building 28, Longfor North Paradise Walk 2, Jinniu District, Sichuan Province, Chengdu, CHN
Pa Shun International Holdings Ltd is an investment holding company engaged in the manufacturing and distribution of pharmaceutical products. The business activity of the group is operated through Pharmaceutical distribution and Pharmaceutical manufacturing segment. Geographically all the activities are carried out in the PRC. The company derives the majority of revenue from the Pharmaceutical distribution segment which include sales of pharmaceutical products to wholesalers, franchise retail pharmacy chain stores and hospitals and other medical institutions in rural areas.
Executives
Zhongtai International Asset Management (singapore) Pte. Ltd. 2102 Investment manager
Arab Osman Mohammed 2104 Agent
Lai Wing Lun 2104 Agent
Win Win Stable No.3 Fund Sp 2106 Person having a security interest in shares
Zhongtai Innovation Capital Management Limited 2102 Investment manager
Chen Yenfei 2101 Beneficial owner
Praise Treasure Limited 2101 Beneficial owner

Pa Shun International Holdings (HKSE:00574) Headlines

No Headlines